Study of the Efficacy and Safety of AMT-101 in Subjects With Ulcerative Colitis (LOMBARD)
Public ClinicalTrials.gov record NCT04583358. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Placebo-controlled, Double-blind, Parallel-group, Multicenter, Phase 2a Study of the Efficacy and Safety of Oral AMT-101 in Subjects With Moderate to Severe Ulcerative Colitis (LOMBARD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Randomized, Placebo-controlled, Double-blind, Parallel-group, Multicenter, Phase 2a Study of the Efficacy and Safety of Oral AMT-101 in Subjects with Moderate to Severe Ulcerative Colitis.
Study identification
- NCT ID
- NCT04583358
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 105 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 26, 2020 (Actual)
- Primary completion
- Nov 30, 2022 (Estimated)
- Completion
- Dec 31, 2022 (Estimated)
- Last update posted
- Nov 7, 2022
2020 – 2022
United States locations
- U.S. sites
- 15
- U.S. states
- 10
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Inland Empire Clinical Trials, LLC | Rialto | California | 92377 | — |
| AdventHealth - Florida Hospital | Orlando | Florida | 32803 | — |
| Advanced Medical Research Center | Port Orange | Florida | 32127 | — |
| Gwinnett Research Institute, LLC | Buford | Georgia | 30519 | — |
| Chevy Chase Clinical Research | Chevy Chase | Maryland | 20815 | — |
| Huron Gastroenterology Associates | Ypsilanti | Michigan | 48197 | — |
| Carolina Research | Greenville | North Carolina | 27834 | — |
| Gastro One | Germantown | Tennessee | 38138 | — |
| GIA Clinical Trials, LLC | Knoxville | Tennessee | 37909 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37212-1375 | — |
| Caprock Gastro Research | Lubbock | Texas | 79424 | — |
| Tyler Research Institute, LLC | Tyler | Texas | 75701 | — |
| University of Utah Hospitals and Clinics | Salt Lake City | Utah | 84112 | — |
| Washington Gastroenterology | Bellevue | Washington | 38004 | — |
| Washington Gastroenterology, PLLC | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04583358, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 7, 2022 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04583358 live on ClinicalTrials.gov.